Healthplus.ai, a Dutch HealthTech company, has secured €2.3 million in growth capital to accelerate its AI platform's development and international expansion, focusing on preventing postoperative infections.
Target Information
Healthplus.ai is a Dutch HealthTech company specializing in the development of artificial intelligence (AI) solutions aimed at improving postoperative care. The company has recently raised €2.3 million in growth capital to accelerate the development and international deployment of its innovative AI platform. This platform is designed to predict the risk of postoperative infections and provide insights that can be linked to treatment actions, thereby reducing complications and recovery times for patients.
Healthplus.ai's technology leverages advanced algorithms to analyze patient data, allowing healthcare providers to make informed decisions and improve overall patient outcomes. The company is poised to play a pivotal role in transforming postoperative care through its AI-driven insights and treatment recommendations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The HealthTech industry in the Netherlands is rapidly evolving, showcasing significant advancements in the integration of technology into healthcare services. Recently, the Dutch government has prioritized heal
Similar Deals
Frazier Life Sciences, Droia Ventures → Alesta Therapeutics
2025
Brightlands Venture Partners → Novenda Technologies
2023
Elevating Capital
invested in
Healthplus.ai
in 2025
in a Series A deal
Disclosed details
Transaction Size: $2M